// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

The role of respiratory syncytial virus and rhinovirus in early recurrent wheeze and asthma inception – a systematic review

Heidi Makrinioti - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Diffuse alveolar haemorrhage in children: an international multicentre study

Astrid Ring - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Feasibility of a virtual multiple breath washout training program

Jacky Wai Yeung Au - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Use of portable spirometers in a paediatric cystic fibrosis clinic

Karin Newton - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Cystic Fibrosis

N/A

Lessons from introducing DEKAs as a means of vitamin supplementation in paediatric Cystic Fibrosis patients

Elizabeth Bearblock - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Cystic Fibrosis

N/A

The impact of Symkevi (Tezacaftor/Ivacaftor) on exercise capacity in adolescents with CF

Molla Imaduddin Ahmed - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Tezacaftor/ivacaftor

Respiratory microbiology outcomes from an observational study of ivacaftor in people with cystic fibrosis and non-G551D gating mutations (VOCAL)

Carlo Castellani - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Cystic Fibrosis

Ivacaftor

Effect of CFTR modulators on exercise tolerance and hand grip strength in CF children

Molla Imaduddin Ahmed - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Ivacaftor/lumacaftor

Estimation of alveolar surface area by functional morphometry utilising a premature baboon model

Theodore Dassios - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Spontaneous preterm delivery

N/A

Development and first results of the BEAT-PCD international Primary Ciliary Dyskinesia gene variant database: CiliaVar

Rahma Mani - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Primary ciliary dyskinesia

N/A

Service delivery models for primary ciliary dyskinesia, an international comparison

Bruna Rubbo - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Primary ciliary dyskinesia

N/A

Does nasal irrigation (NI) improve outcomes in children with primary ciliary dyskinesia (PCD)?: a scoping review

Amanda Lea Harris - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Primary ciliary dyskinesia

N/A

Face mask usage against SARS-CoV-2 among people with primary ciliary

Eva Sophie Lunde Pedersen - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Teaching Air Pollution to Children - Clinical research and education colliding

Abigail Whitehouse - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Does lung function change in the months after an asthma exacerbation in children?

Joanne Martin - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Postnatal diuretics, growth and home oxygen requirement in preterm infants

Emma Williams - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Hydroxyzine

Use of postnatal corticosteroids and weight gain in extremely prematurely born infants

Emma Williams - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Hydrocortisone

Dietary patterns and lung function in childhood: A longitudinal study

Mohammad Talaei Pashiri - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Characterisation of severity in paediatric chronic suppurative lung disease

Virginia Alessandrini - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Azithromycin

Impaired response to 13-valent pneumococcal conjugate vaccine (PCV13) in children with recurrent respiratory infections and chronic cough

Moataz Elashmawy - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

13-valent pneumococcal conjugate vaccine

Copyright © 2026. QuantiNova All rights reserved